Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remodelling: therapeutic opportunities

A Lafont1, Z Grati, F Addad

  • 1Hôpital Boucicaut, University Paris V, France.

Seminars in Interventional Cardiology : SIIC
|July 3, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicinal plant-derived nanovesicles for skin delivery: A natural biovector for therapeutics and cosmetics.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Factors associated with patent foramen ovale-related stroke: SAFAS study.

Revue neurologique·2023
Same author

Contextuality and context-sensitivity in probabilistic models of cognition.

Cognitive psychology·2022
Same author

[stent thrombosis : A won battle ? (data from the France PCI registry)].

Annales de cardiologie et d'angeiologie·2021
Same author

Semiquantitative analysis of interim <sup>18</sup>F-FDG PET is superior in predicting outcome in Hodgkin lymphoma patients compared to visual analysis.

Revista espanola de medicina nuclear e imagen molecular·2021
Same author

Inhibiting Type VI Secretion System Activity with a Biomimetic Peptide Designed To Target the Baseplate Wedge Complex.

mBio·2021
Same journal

Atherectomy plus stenting: what do we gain?

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of directional coronary atherectomy for the treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of rotablator for treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

Directional coronary atherectomy: optimal atherectomy trials and new combined strategies with coronary stents.

Seminars in interventional cardiology : SIIC·2001
Same journal

Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.

Seminars in interventional cardiology : SIIC·2001
Same journal

Morphological analysis of atherosclerotic plaque retrieved by coronary atherectomy.

Seminars in interventional cardiology : SIIC·2001
See all related articles

Restenosis after angioplasty is now linked to artery remodeling, not just neointimal growth. Stent restenosis, however, still involves neointimal growth, guiding targeted therapies.

Area of Science:

  • Cardiovascular Research
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Restenosis post-angioplasty was previously attributed to neointimal growth.
  • Recent findings suggest compensatory enlargement or chronic constrictive remodeling are key factors.
  • Stent-related restenosis is consistently linked to neointimal proliferation.

Purpose of the Study:

  • To differentiate mechanisms of restenosis after angioplasty versus stenting.
  • To guide the development of targeted therapeutic strategies.
  • To investigate the role of extracellular matrix metabolism in constrictive remodeling.

Main Methods:

  • Review and synthesis of current research on post-angioplasty and post-stent restenosis.
  • Analysis of mechanisms including neointimal growth, compensatory enlargement, and constrictive remodeling.

Related Experiment Videos

  • Exploration of potential therapeutic targets, such as antiproliferative agents and extracellular matrix modulation.

    • Main Results:

    • Restenosis after angioplasty is primarily due to lack of compensatory enlargement and/or constrictive remodeling.
    • Stent-related restenosis is predominantly caused by neointimal growth.
    • Antiproliferative strategies have shown success against stent restenosis.

    Conclusions:

    • Understanding distinct restenosis mechanisms is crucial for effective treatment design.
    • Controlling extracellular matrix metabolism may be a target for managing constrictive remodeling.
    • Identifying arteries prone to enlargement could help avoid unnecessary stenting.